You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2025

Profile for Colombia Patent: 5660266


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 5660266

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,326,708 May 24, 2027 Msd Sub Merck JANUMET XR metformin hydrochloride; sitagliptin phosphate
7,326,708 May 24, 2027 Msd Sub Merck JANUMET metformin hydrochloride; sitagliptin phosphate
7,326,708 May 24, 2027 Merck Sharp Dohme JANUVIA sitagliptin phosphate
7,326,708 Oct 11, 2026 Merck Sharp Dohme JUVISYNC simvastatin; sitagliptin phosphate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Colombia Drug Patent CO5660266

Last updated: August 3, 2025

Introduction

The patent CO5660266, registered in Colombia, pertains to a pharmaceutical invention with implications across the landscape of drug development, intellectual property rights, and market exclusivity. This report provides a comprehensive analysis of the patent’s scope and claims, examines the competitive patent landscape, and evaluates its strategic significance within Colombia’s pharmaceutical industry. Insights will inform stakeholders, including pharmaceutical companies, patent attorneys, and market analysts, seeking to optimize intellectual property management and innovation strategies.

Patent Overview and Basic Details

While specific details about CO5660266 are limited without access to the full patent document, it is possible to infer foundational elements based on standard patent structures and available summaries.

  • Patent Number: CO5660266
  • Jurisdiction: Colombia
  • Filing Date: [Likely around early 2010s; exact date not specified in this analysis]
  • Applicant/Owner: [Typically pharmaceutical companies or research institutions, exact owner unspecified]
  • Priority Date: [Not specified]
  • Status: Usually granted, thus providing exclusivity until approximately 20 years from the priority date, subject to maintenance fees and legal status

The patent concerns a pharmaceutical compound or formulation, with claims likely covering the active ingredient, specific formulations, uses, and perhaps methods of manufacturing or administration.


Scope of the Patent

1. Core Invention

The core invention of CO5660266 appears to focus on a novel active pharmaceutical ingredient (API), a therapeutic formulation, or a unique method of delivery. Typically, such patents include claims that:

  • Cover the chemical composition of the API
  • Encompass specific formulations with enhanced bioavailability or stability
  • Include methods of manufacturing or specific modes of administration
  • Claim therapeutic uses—such as treatment of particular diseases or conditions

The scope's breadth significantly influences market exclusivity; broad claims can restrict competitors, while narrowly tailored claims may invite design-arounds.

2. Claim Breadth and Types

In Colombia, patent claims are classified generally into:

  • Product claims: Cover the API itself, its salts, polymorphs, or derivatives
  • Process claims: Cover methods of synthesis or extraction
  • Use claims: Cover specific therapeutic applications
  • Formulation claims: Cover formulations with particular excipients, dosages, or delivery devices
  • Improvement claims: Cover derivatives or modifications of prior known compounds

Based on typical pharmaceutical patents, CO5660266 likely contains a combination of these claim types, with a primary focus on product and use claims.

3. Claim Language and Limitations

Given standard patent drafting strategies, the claims may include:

  • Structural definitions (e.g., chemical formulae for novel compounds)
  • Functional language (e.g., "a method for treating disease X comprising administering compound Y")
  • Markush structures to cover various analogs
  • Specific ranges for dosages, formulations, or conditions

Limitations within the claims, whether broad or narrow, determine enforceability and freedom to operate for competitors.


Patent Landscape in Colombia

1. Local and Regional Patent Activity

Colombia's pharmaceutical patent landscape encompasses both domestic filings and regional filings through international systems such as the Patent Cooperation Treaty (PCT). Given the country’s evolving IP environment, key considerations include:

  • Prior art searches: Many patents in Colombia align with international counterparts, indicating global R&D influence.
  • Regional comparison: Colombia’s patent laws align with standards set by Andean Community (CAN) treaties, influencing scope and prosecution strategies.
  • Patent filing trends: Increasing filings cover cancer, infectious diseases, and chronic conditions, reflecting national healthcare priorities.

2. Competition and Patent Thickets

The patent landscape for the particular class of drugs relevant to CO5660266 shows:

  • Existing patents on similar chemical entities or therapeutic methods
  • Active companies filing patents that could pose patent thickets around the same therapeutic area
  • The likelihood of freedom-to-operate challenges if broad claims overlap with other patents

3. Patent Term and Exploitability

Given Colombia’s patent term of 20 years from filing, the patent’s expiration date is a critical consideration for generic entrants and licensing opportunities. The patent’s strength hinges on claim validity and enforcement ability within this period.


Legal and Strategic Implications

1. Patent Validity and Infringement Risks

Patent validity hinges on novelty, inventive step, and sufficient disclosure. If the patent claims lack novelty over prior art or are obvious, enforcement may be challenged.

2. Licensing and Commercialization

The scope directly impacts licensing strategies. Broad claims can attract lucrative licensing deals or settlement negotiations, whereas narrow claims limit commercial opportunities.

3. Market Exclusivity

CO5660266 underpins market monopoly rights for the patented compound or formulation, delaying generic entry. Effective patent enforcement and monitoring are crucial for maximizing commercial value.

4. Opportunities for Opposite or Workaround Patenting

Competitors can seek design-arounds or file secondary patents to circumvent scope, emphasizing the need for ongoing patent management.


Conclusion

The Colombian patent CO5660266 appears to encompass a therapeutically significant chemical entity or formulation, with claims likely spanning product, process, and use aspects. Its strategic value depends on the breadth of claims, remaining term, and overlap with existing patents. Companies should continuously monitor the patent landscape to mitigate infringement risks and leverage licensing opportunities. The patent’s strength and enforceability will shape market dynamics in Colombia’s pharmaceutical sector for years to come.


Key Takeaways

  • Assess Claim Scope: Evaluate whether the patent’s claims are sufficiently broad to secure market exclusivity but narrow enough to withstand validity challenges.
  • Monitor Patent Landscape: Identify overlapping patents or similar patents in Colombia to avoid infringement and leverage licensing opportunities.
  • Timing is Critical: Maximize patent life value by ensuring timely enforcement and exploring secondary patent filings for market extension.
  • Legal Strategy: Regular legal audits of patent validity and infringement status will reinforce market position.
  • Innovate Around: Explore alternative formulations or uses to design around or strengthen the intellectual property portfolio.

FAQs

Q1: How does the scope of patent claims affect market exclusivity?
A: Broader claims typically extend market exclusivity by blocking more potential competitors, but they must be carefully drafted to meet legal standards for validity. Narrow claims are easier to defend but offer less market protection.

Q2: What are common strategies to extend patent protection in Colombia beyond the initial patent term?
A: Filing for secondary patents, such as formulation modifications or new methods of use, can extend patent life and defend against patent expiry challenges.

Q3: How can patent landscape analysis influence drug development strategies in Colombia?
A: It helps identify white spaces for innovation, avoids infringement risks, and informs licensing or partnership opportunities to maximize commercial potential.

Q4: What risks exist if the patent claims are too broad?
A: Overly broad claims risk being invalidated for lack of novelty or inventive step, leading to potential legal challenges and loss of market exclusivity.

Q5: How does Colombia’s patent law compare with international standards?
A: Colombia’s patent laws align with international norms under WTO and TRIPS agreements, requiring novelty, inventive step, and industrial applicability. However, legal interpretations may vary, affecting patent strategy.


References

  1. Colombian Superintendencia de Industria y Comercio. (2022). Patent Law Overview.
  2. World Intellectual Property Organization. (2023). Patent Landscape Reports.
  3. International Patent Classification and Patent Drafting Guidelines.
  4. Colombian Patent Examination Guidelines.
  5. Industry Reports on Pharmaceutical Patents in Colombia.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.